NKTX - Nkarta Inc
2.57
-0.010 -0.389%
Share volume: 751,151
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.58
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-07-2024 | 03-26-2025 | 05-14-2025 | 11-10-2025 | |
| Assets | |||||||
| Total Assets | 576.936 M | 554.086 M | 532.034 M | 501.203 M | 470.609 M | 427.236 M | |
| Current Assets | 442.781 M | 331.799 M | 290.150 M | 273.338 M | 271.551 M | 289.275 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 187.109 M | 204.423 M | 226.095 M | 239.481 M | 212.909 M | 222.217 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 250.285 M | 120.398 M | 56.960 M | 27.873 M | 52.598 M | 60.114 M | |
| Total Non-current Assets | 9.814 M | 99.086 M | 119.467 M | 110.392 M | 83.651 M | 31.421 M | |
| Property Plant Equipment | 78.522 M | 77.551 M | 76.231 M | 74.658 M | 72.625 M | 68.182 M | |
| Other Assets | 55.633 M | 144.736 M | 165.653 M | 153.207 M | 126.433 M | 69.779 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 576.936 M | 554.086 M | 532.034 M | 501.203 M | 470.609 M | 427.236 M | |
| Total liabilities | 103.285 M | 100.902 M | 101.161 M | 93.227 M | 91.804 M | 89.336 M | |
| Total current liabilities | 22.189 M | 20.861 M | 22.468 M | 18.917 M | 18.756 M | 18.988 M | |
| Accounts Payable | 3.177 M | 3.764 M | 1.937 M | 638.000 K | 1.490 M | 1.437 M | |
| Other liabilities | 81.096 M | 80.041 M | 78.693 M | 74.310 M | 73.048 M | 70.348 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 81.096 M | 80.041 M | 78.693 M | 74.310 M | 73.048 M | 70.348 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 473.651 M | 453.184 M | 430.873 M | 407.976 M | 378.805 M | 337.900 M | |
| Common stock | 938.730 M | 943.392 M | 947.448 M | 951.526 M | 954.360 M | 958.263 M | |
| Retained earnings | -464.952 M | -489.945 M | -518.289 M | -544.224 M | -576.207 M | -620.899 M |